XML 84 R41.htm IDEA: XBRL DOCUMENT v3.25.1
FINANCIAL INSTRUMENTS - Narrative (Details)
$ in Thousands
12 Months Ended
Sep. 20, 2023
USD ($)
shares
Aug. 02, 2023
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
shares
Financial Instruments [Line Items]        
Issuance of common stock in acquisition of Apton       $ 76,642
Issuance of common stock following milestone achievement (in shares) | shares       8,988,391
Issuance of common stock following milestone achievement       $ 84,761
Investment income, net     $ 24,900 32,800
Omniome, Inc        
Financial Instruments [Line Items]        
Total cash paid $ 100,900      
Issuance of common stock in acquisition (in shares) | shares 9,000,000      
Issuance of common stock in acquisition of Apton $ 95,900      
Milestone revenue       $ 101,300
Omniome, Inc | Common Stock        
Financial Instruments [Line Items]        
Issuance of common stock in acquisition of Apton 100,000      
Omniome, Inc | Employee Stock Option        
Financial Instruments [Line Items]        
Issuance of common stock in acquisition of Apton $ 4,100      
Apton        
Financial Instruments [Line Items]        
Business acquisition, anniversary   5 years    
Total cash paid   $ 200    
Issuance of common stock in acquisition (in shares) | shares   6,121,571   6,300,000
Average trading period   20 days    
Omniome        
Financial Instruments [Line Items]        
Average trading period 20 days      
Minimum | Valuation, Income Approach | Measurement Input, Risk Free Interest Rate        
Financial Instruments [Line Items]        
Discount rates     0.094  
Maximum | Valuation, Income Approach | Measurement Input, Risk Free Interest Rate        
Financial Instruments [Line Items]        
Discount rates     0.096